Aggregation of human platelets induced by porcine endothelial cells is dependent upon both activation of complement and thrombin generation

Xenotransplantation

Volumn 3, Issue 1 PART 1, 1996, Pages 24-34

  Robson, Simon C ^a,c   Siegel, Jonathan B ^a   Lesnikoski, Beth A ^a   Kopp, Christoph ^a   Candinas, Daniel ^a   Ryan, Una ^b   Bach, Fritz H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b T Cell Sciences Inc   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Complement; Endothelial cell; Hyperacute rejection; Platelets; Thrombin; Xenotransplantation

Indexed keywords

EID: 0030019008     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1996.tb00115.x     Document Type: Article

References (38)

1. PLATT JL, VERCELLOTTI GM, DALMASSO AP, MATAS AJ, BOLMAN RM, NAJARIAN JS, BACH FH. Transplantation of discordant xenografts: a review progress. Immunol Today 1990:11:450.
2. BACH FH, ROBSON SC, FERRAN C, WINKLER H, MILLAN MT, STUHLMEIER K, VANHOVE B, BLAKELY ML, VAN DER WERF WJ, HOFER E, DE MARTIN R, HANCOCK WW. Endothelial cell activation and thromboregulation during xenograft rejection. Immun Rev 1994:141:5.
3. ROBSON SC, CANDINAS D, HANCOCK WW, WRIGHTON C, WINKLER H, BACH FH. Role of endothelial cells in transplantation. Int Arch Allergy Immunol 1995:106:305.
4. WIEDMER T, ESMON CT, SIMS PJ. On the mechanism by which complement proteins C5b-9 increase platelet prothrombinase activity. J Biol Chem 1986:261:14587.
5. SIMS PJ, WIEDMER T. The response of human platelets to activated components of the complement system. Immunol Today 1991:12(9):338.
6. BALDWIN WM III, PRUITT SK, BRAUER RB, DAHA MR, SANFILIPPO F. Complement in organ transplantation. Transplantation 1995:59(6):797.
7. ROBSON SC, SAUNDERS R, DE JAGER C, PURVES L, KIRSCH RE. Fibrin and fibrinogen degradation products with an intact D-domain C-terminal gamma chain inhibit an early step in accessory cell dependent lymphocyte mitogenesis. Blood 1993:81:3006.
8. MOSESSON MW. The roles of fibrinogen and fibrin in hemostasis and thrombosis. Semin Hematol 1992:29:177.
9. ROBSON SC, KOPP C, LESNIKOSKI BA. Platelet reactivity in xenograft rejection. Xenotransplantation 1994:2:38.
10. PARETI FI, MAZZUCATO M, BOTTINI E, MANNUCCI PM. Interaction of porcine von Willebrand factor with the platelet glycoproteins Ib and IIb/IIIa complex. Br J Haematol 1992:82:81.
11. ++-dependent exocytotic elimination of C5b-9 pores. Blood 1986:68:556.
12. RYAN US, MAXWELL G. Isolation, culture and subculture of endothelial cells: mechanical methods. J Tissue Culture Methods 1986:10:3.
13. MARCUS AJ, SAFIER LB, HAJJAR KA, ULLMAN HL, ISLAM N, BROEKMAN MJ, EIROA AM. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase: thromboregulation by endothelial cells. J Clin Invest 1991:88:1690.
14. SPANNAGL M, BICHLER J, BIRG A, LILL H, SCHRAMM W. Development of a chromogenic assay for the determination of hirudin in plasma. Blood Coag Fibrinolysis 1991:2:121.
15. DALMASSO AP, PLATT JL, BACH FH. Reaction of complement with endothelial cells in a model of xenotransplantation. Clin Exp Immunol 1991:86:31.
16. 3 integrins (GPIIb-IIIa) and the Expression of P-selectin and procoagulant activity. J Exp Med 1993:178:579.
17. CARSON SD, JOHNSON DR. Consecutive enzyme cascades: complement activation at the cell surface triggers increased tissue factor activity. Blood 1990:76:361.
18. BRAUER RB, BALDWIN III WM, IBRAHIM S, SANFILIPPO F. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat. Transplantation 1995:59:288.
19. BRAUER RB, BALDWIN WM, DAHA MR, PRUITT SK, SANFILIPPO F. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol 1993:151:7240.
20. PRUITT SK, BALDWIN III WM, MARSH HC JR, LIN SS, YEH CG, BOLLINGER RR. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 1991:52:868.
21. ZEBRA KJ, HERSKOWITZA, LEE PC, KUMAR P, GILLINOV AM, BAUMGARTNER WA. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species. Transplantation 1994:57:900.
22. PRUITT SK, DIRK AD, BOLLINGER RR, MARSH HC, COLLINS BH, LEVIN JL, MAULT JR, HEINLE JS, IBRAHIM S, RUDOLPH AR, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994:57:363.
23. DALMASSO AP, PLATT JL. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor. Transplantation 1993:56:1171.
24. MCCURRY KR, KOOYMAN DL, ALVARADO CG, COTTERELL AH, MARTIN MJ, LOGAN JS, PLATT JL. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Medicine 1995:1:423.
25. BLAKELY ML, VAN DER WERF WJ, BERNDT MC, DALMASSO AP, BACH FH, HANCOCK WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994:58:1059.
26. ALBELDA SM, SMITH CW, WARD PA. Adhesion molecules and inflammatory injury. FASEB J 1994:8:504.
27. COOK NS, KOTTIRSCH G, ZERWES H. Platelet glycoprotein IIb/IIIa antagonists. Drugs Future 1994:19:135.
28. DELISSER HM, YAN HC, NEWMAN PJ, MULLER WA, BUCK CA, ALBELDA SM. Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. J Biol Chem 1993:268:16037.
29. SALZMAN EW, ROSENBERG RD, SMITH MH, LINDON JN, FAVREAU L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 1990:65:64.
30. STORCK J, HOLLGER N, ZIMMERMANN RE. The influence of heparin and protamine sulfate on platelet ADP and platelet factor 4 release and the expression of glycoprotein IIb/ IIIa. Haemostasis 1994:24:6:358.
31. 2 release by adherent neutrophil leukocytes. J Immunol 1995:154:1383.
32. BIEDERMANN B, ROSENMUND A, MULLER M, KOHLER HP, HAEBERLI A, STRAUB PW. Human endothelial cells suppress prothrombin activation in nonanticoagulated whole blood in vitro. J Lab Clin Med 1994:124:3:339.
33. TIJBURG PNM, VAN HEERDE WL, LEENHOUTS HM, SEHHING M, BOUMA BN, DE GROOT PG. Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation on endothelial cells. J Biol Chem 1991:266:4017.
34. TIJBURG PNM, DE GROOT PG. Endothelial cell-mediated thrombin formation. Semin Thromb Hemost 1992:18:256.
35. SAADI S, PLATT JL. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med 1995:181:21.
36. DORLING A, LECHLER RI. Prospects for xenotransplantation. Curr Opinion Immunol 1994:6:765.
37. NOWAK R. Xenotransplants set to resume. Science 1994:266:1148.
38. LU CY, KHAIR-EL-DIN TA, DAWIDSON IA, BUTLER TM, BRASKY KM, VAZQUEZ MA, SICHER SC. Xenotransplantation. FASEB J 1994:8:1122.